drugset / Trial / NCT01721408

A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection

NCT01721408

Phase 4 Completed 470 enrolled Pfizer
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a comparative study of the efficacy and safety of tigecycline to imipenem/cilastatin in hospitalized patients with a complicated intra-abdominal infection.

Timeline

Start
2012-11
Primary completion
2015-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cilastatin Small molecule 500 mg Intravenous
Comparator IMIPENEM ANHYDROUS Small molecule 500 mg Intravenous
Subject Tigecycline Small molecule 50 mg Intravenous